Metric Finance
LearnFAQ
LearnFAQ

Learn / FTH

NASDAQ: FTH

Faeth Therapeutics (FTH) stock, explained like you're 5

Faeth Therapeutics trades on the Nasdaq under the ticker FTH. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 673 million dollars.

Ticker
FTH
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 673 million dollars

Is Faeth Therapeutics a small, medium or large cap company?

No. Faeth Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 673 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Faeth Therapeutics makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves FTH stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • William Blair initiates Faeth Therapeutics stock with outperform rating (Investing.com)
  • (FTH) Risk Channels and Responsive Allocation (Stock Traders Daily)
  • FTH 8 K & SEC Filings (Yahoo! Finance Canada)
  • Faeth Therapeutics, Inc. Common Stock (Nasdaq:FTH) Stock Quote (FinancialContent)
  • FTH Upgraded by William Blair Rating Set to Outperform (GuruFocus)

Follow FTH in your daily brief

Each trading day at 5 PM ET we post what happened to Faeth Therapeutics and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow FTH

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Faeth Therapeutics stock

What does Faeth Therapeutics do?

Faeth Therapeutics trades on the Nasdaq under the ticker FTH. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 673 million dollars.

What is the ticker symbol for Faeth Therapeutics?

Faeth Therapeutics trades under the ticker FTH on the Nasdaq.

What is Faeth Therapeutics's market cap?

Faeth Therapeutics is a small cap stock with a market cap of about 673 million dollars.

How does Faeth Therapeutics make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves FTH stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow FTH stock every day?

Add FTH to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow FTH daily

A free brief on Faeth Therapeutics and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare FTH: FTH vs NVS, FTH vs AZN, FTH vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed